CORD-19:2008f024274c53b0de1276f4047a6a641813fd98 / 464995-465275 JSONTXT 2 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T87324 0-280 Sentence denotes In contrast, inhalation of the short-acting bronchodilator salbutamol led to a distinct improvement in FEV 1 versus baseline in all treatments groups with median FEV 1 increases of 19%, 21%, and 14% in the roflumilast 1000 μg, roflumilast 500 μg, and placebo groups, respectively.